Russell Investments Group Ltd. Has $505,000 Stock Holdings in Surgery Partners, Inc. $SGRY

Key Points

• Russell Investments Group Ltd. has significantly increased its stake in Surgery Partners, Inc. ($SGRY) by 241.0% in Q1, owning a total of 21,257 shares valued at approximately $505,000.
• Surgery Partners reported an earnings per share of $0.17 for the latest quarter, exceeding analysts' expectations, and the company's revenue grew by 8.4% compared to the previous year.
• A number of analysts have rated Surgery Partners with a consensus rating of "Moderate Buy" and a target price of $33.00, indicating positive sentiment among investors.

Russell Investments Group Ltd. boosted its stake in shares of Surgery Partners, Inc. (NASDAQ:SGRY - Free Report) by 241.0% during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 21,257 shares of the company's stock after acquiring an additional 15,024 shares during the period. Russell Investments Group Ltd.'s holdings in Surgery Partners were worth $505,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently added to or reduced their stakes in the stock. Point72 Asia Singapore Pte. Ltd. increased its stake in shares of Surgery Partners by 12.1% in the 4th quarter. Point72 Asia Singapore Pte. Ltd. now owns 4,296 shares of the company's stock valued at $91,000 after purchasing an additional 465 shares during the last quarter. PNC Financial Services Group Inc. boosted its holdings in shares of Surgery Partners by 86.4% during the 1st quarter. PNC Financial Services Group Inc. now owns 1,169 shares of the company's stock valued at $28,000 after acquiring an additional 542 shares in the last quarter. Mackenzie Financial Corp boosted its holdings in shares of Surgery Partners by 2.8% during the 4th quarter. Mackenzie Financial Corp now owns 21,974 shares of the company's stock valued at $465,000 after acquiring an additional 599 shares in the last quarter. Bank of New York Mellon Corp boosted its holdings in shares of Surgery Partners by 0.3% during the 1st quarter. Bank of New York Mellon Corp now owns 341,702 shares of the company's stock valued at $8,115,000 after acquiring an additional 926 shares in the last quarter. Finally, MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its holdings in shares of Surgery Partners by 3.9% during the 4th quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 43,678 shares of the company's stock valued at $925,000 after acquiring an additional 1,640 shares in the last quarter.

Wall Street Analysts Forecast Growth

Several equities research analysts recently weighed in on the company. Bank of America assumed coverage on Surgery Partners in a report on Monday, July 28th. They set a "buy" rating and a $28.00 price objective on the stock. Barclays cut their price objective on Surgery Partners from $25.00 to $24.00 and set an "equal weight" rating on the stock in a report on Tuesday, May 27th. Six analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company's stock. According to MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and an average price target of $33.00.

Surgery Partners Trading Up 0.7%

SGRY traded up $0.15 during midday trading on Friday, hitting $22.51. 1,035,308 shares of the company were exchanged, compared to its average volume of 1,316,687. The firm has a market capitalization of $2.89 billion, a P/E ratio of -15.74 and a beta of 1.76. Surgery Partners, Inc. has a 1-year low of $18.87 and a 1-year high of $33.90. The firm's 50 day moving average price is $22.48 and its 200-day moving average price is $22.70. The company has a quick ratio of 1.78, a current ratio of 1.93 and a debt-to-equity ratio of 1.10.

Surgery Partners (NASDAQ:SGRY - Get Free Report) last announced its earnings results on Tuesday, August 5th. The company reported $0.17 EPS for the quarter, topping the consensus estimate of $0.16 by $0.01. The firm had revenue of $826.20 million for the quarter, compared to the consensus estimate of $816.96 million. Surgery Partners had a positive return on equity of 2.51% and a negative net margin of 5.57%.The business's quarterly revenue was up 8.4% compared to the same quarter last year. During the same period in the previous year, the business earned $0.21 EPS. As a group, equities analysts forecast that Surgery Partners, Inc. will post 0.67 EPS for the current fiscal year.

Insider Buying and Selling

In other Surgery Partners news, Director Teresa Deluca sold 20,018 shares of Surgery Partners stock in a transaction dated Monday, August 11th. The stock was sold at an average price of $22.74, for a total transaction of $455,209.32. Following the transaction, the director directly owned 45,173 shares of the company's stock, valued at approximately $1,027,234.02. The trade was a 30.71% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Insiders own 2.70% of the company's stock.

About Surgery Partners

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.